Stephen Covington, DO
Pain Medicine · Scottsdale, AZNPI 1063944080
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,616 of the $3,563 with a category attached, or 73.4%. 10 manufacturers reported payments, led by Nevro Corp. at 42.3% of the total. Reporting peaked in 2021 at $1,390 and has fallen 69.5% since, to $423 in 2025. That places this record below the midpoint for pain medicine clinicians in AZ, where the typical reported total is $3,853.
Across 41 payments — averaging $86.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Abbott$973
- Medtronic$711
- Averitas Pharma Inc.$122
- Boston Scientific$58
- Johnson & Johnson$56
- plus $135 from 4 others
What the payments were for
- Travel & lodging$2246%
- Food & beverage$2,61673%
- Education$72320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 13 | $1,507 |
| Abbott | 11 | $973 |
| Medtronic | 9 | $711 |
| Averitas Pharma Inc. | 1 | $122 |
| Boston Scientific | 2 | $58 |
| Johnson & Johnson | 1 | $56 |
| Biotronik NRO, Inc. | 1 | $46 |
| Stryker | 1 | $34 |
| SPR Therapeutics, Inc | 1 | $32 |
| Globus Medical | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$1,093
- PROCLAIM$532
- INCEPTIV$172
- INTELLIS ADAPTIVESTIM$169
- Senza$144
- Vanta$137
- Proclaim IPG$131
- OCTRODE$128
- Qutenza$122
How this compares
$3,563 in reported general payments places this provider in the 45th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 55 | $871 |
| Gabapentin | 55 | $633 |
| Metaxalone | 14 | $601 |
| Cyclobenzaprine Hcl | 29 | $565 |
| Duloxetine Hcl | 26 | $363 |
| Celecoxib | 17 | $185 |
| Methocarbamol | 16 | $117 |
| Meloxicam | 24 | $71 |
| Alprazolam | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Scottsdale
- Tory McJunkinScottsdale$204K
- Vivek IyerScottsdale$70K
- Avijit SharmaScottsdale$23K
- Natalie StrandScottsdale$22K
- Jason JensenScottsdale$21K
- Matthew CrooksScottsdale$21K
- Nikesh SethScottsdale$15K
- Ashu GoyleScottsdale$10K
- Monica TorresScottsdale$8K
- Eric CornidezTucson$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.